Results 2,281-2,300 of 7,412 for speaker:Neasa Hourigan

Public Accounts Committee: 2021 Financial Statements of the State Claims Agency: Discussion
Chapter 20: Management of the Clinical Indemnity Scheme of the Report on the Accounts of Public Services 2021 (2 Mar 2023)

Neasa Hourigan: Does that present a problem because it speaks to the formality of whether the SCA is advising Departments on what they are going to do?

Public Accounts Committee: 2021 Financial Statements of the State Claims Agency: Discussion
Chapter 20: Management of the Clinical Indemnity Scheme of the Report on the Accounts of Public Services 2021 (2 Mar 2023)

Neasa Hourigan: I am sorry; I keep saying that. It is the HSE.

Public Accounts Committee: 2021 Financial Statements of the State Claims Agency: Discussion
Chapter 20: Management of the Clinical Indemnity Scheme of the Report on the Accounts of Public Services 2021 (2 Mar 2023)

Neasa Hourigan: To be clear, the use of the word "may" is not so relevant for the HSE and how it behaves but more for the State Claims Agency and how it behaves.

Public Accounts Committee: 2021 Financial Statements of the State Claims Agency: Discussion
Chapter 20: Management of the Clinical Indemnity Scheme of the Report on the Accounts of Public Services 2021 (2 Mar 2023)

Neasa Hourigan: So it is "shall"?

Public Accounts Committee: 2021 Financial Statements of the State Claims Agency: Discussion
Chapter 20: Management of the Clinical Indemnity Scheme of the Report on the Accounts of Public Services 2021 (2 Mar 2023)

Neasa Hourigan: That formalises it somewhat. Dr. O'Keeffe is advising that the formal way of doing that is through the joint governance group.

Public Accounts Committee: 2021 Financial Statements of the State Claims Agency: Discussion
Chapter 20: Management of the Clinical Indemnity Scheme of the Report on the Accounts of Public Services 2021 (2 Mar 2023)

Neasa Hourigan: Is that set out anywhere as a process? If I was trying to follow this and go through all the public records, is there a process I could follow that is legible and, for example, in which I can see that the agency advised the HSE of a certain thing?

Public Accounts Committee: 2021 Financial Statements of the State Claims Agency: Discussion
Chapter 20: Management of the Clinical Indemnity Scheme of the Report on the Accounts of Public Services 2021 (2 Mar 2023)

Neasa Hourigan: I am not asking about all the different routes. If there is a significant issue that the agency has identified, is there a priority pathway I can follow to make legible to me the conversation between the HSE and the agency around a recurring risk?

Public Accounts Committee: 2021 Financial Statements of the State Claims Agency: Discussion
Chapter 20: Management of the Clinical Indemnity Scheme of the Report on the Accounts of Public Services 2021 (2 Mar 2023)

Neasa Hourigan: I take all those points. For somebody who is trying to follow a particular issue, it seems a bit nebulous. I wish to go back to non-disclosure agreements. My interest was piqued. The agency does not have data relating to that issue. In 2021, for example, of the cases settled without mediation, will Mr. Breen hazard a guess at how many included an NDA in some form?

Public Accounts Committee: 2021 Financial Statements of the State Claims Agency: Discussion
Chapter 20: Management of the Clinical Indemnity Scheme of the Report on the Accounts of Public Services 2021 (2 Mar 2023)

Neasa Hourigan: Who were they led by?

Public Accounts Committee: 2021 Financial Statements of the State Claims Agency: Discussion
Chapter 20: Management of the Clinical Indemnity Scheme of the Report on the Accounts of Public Services 2021 (2 Mar 2023)

Neasa Hourigan: How often does the agency advise the HSE and more generally? We heard about a particular instance at last week's committee meeting where we were told the agency had advised to move ahead with a particular settlement that included an NDA. How often does that happen?

Public Accounts Committee: 2021 Financial Statements of the State Claims Agency: Discussion
Chapter 20: Management of the Clinical Indemnity Scheme of the Report on the Accounts of Public Services 2021 (2 Mar 2023)

Neasa Hourigan: We might send on some details.

Public Accounts Committee: 2021 Financial Statements of the State Claims Agency: Discussion
Chapter 20: Management of the Clinical Indemnity Scheme of the Report on the Accounts of Public Services 2021 (2 Mar 2023)

Neasa Hourigan: That makes the agency a party to the whole process.

Public Accounts Committee: 2021 Financial Statements of the State Claims Agency: Discussion
Chapter 20: Management of the Clinical Indemnity Scheme of the Report on the Accounts of Public Services 2021 (2 Mar 2023)

Neasa Hourigan: We are talking about mediation now, not settlements?

Public Accounts Committee: 2021 Financial Statements of the State Claims Agency: Discussion
Chapter 20: Management of the Clinical Indemnity Scheme of the Report on the Accounts of Public Services 2021 (2 Mar 2023)

Neasa Hourigan: I take that point.

Public Accounts Committee: 2021 Financial Statements of the State Claims Agency: Discussion
Chapter 20: Management of the Clinical Indemnity Scheme of the Report on the Accounts of Public Services 2021 (2 Mar 2023)

Neasa Hourigan: That seems contrary to what we were told.

Public Accounts Committee: 2021 Financial Statements of the State Claims Agency: Discussion
Chapter 20: Management of the Clinical Indemnity Scheme of the Report on the Accounts of Public Services 2021 (2 Mar 2023)

Neasa Hourigan: Are the witnesses aware, regarding advice it has given, of a case with two parties where the State does not have a representative in the room and, therefore, is neither of the parties? Is the State involved in any settlements or court cases like that? That is what was described to us last week. Are the witnesses aware of any similar cases in which there are two parties to an agreement and...

Public Accounts Committee: 2021 Financial Statements of the State Claims Agency: Discussion
Chapter 20: Management of the Clinical Indemnity Scheme of the Report on the Accounts of Public Services 2021 (2 Mar 2023)

Neasa Hourigan: I am thankful. That information is helpful for my question. Regarding trying to follow the path around records in this context, I wonder if it would be possible for the SCA to provide the committee with a briefing note in this regard or perhaps even the correspondence between the SCA and the HSE on this issue, concerning where the risk is highlighted.

Public Accounts Committee: 2021 Financial Statements of the State Claims Agency: Discussion
Chapter 20: Management of the Clinical Indemnity Scheme of the Report on the Accounts of Public Services 2021 (2 Mar 2023)

Neasa Hourigan: No, I get that and Dr. O'Keeffe said already that this was part of a more general conversation. I am going to say this again, however. There is a specific risk in here-----

Public Accounts Committee: 2021 Financial Statements of the State Claims Agency: Discussion
Chapter 20: Management of the Clinical Indemnity Scheme of the Report on the Accounts of Public Services 2021 (2 Mar 2023)

Neasa Hourigan: -----with the failure to implement e-health records or some kind of a system like that.

Public Accounts Committee: 2021 Financial Statements of the State Claims Agency: Discussion
Chapter 20: Management of the Clinical Indemnity Scheme of the Report on the Accounts of Public Services 2021 (2 Mar 2023)

Neasa Hourigan: It is a very simple question really. Could the SCA provide us at any stage with either minutes or correspondence whereby it cited for the HSE that this was an ongoing risk?